Company Overview
- Headquarters
- 300 Technology Square, 8th Floor, Cambridge MA
- Website
- judo.bio
- Employees
- 19
- Industry
- Biotech/Healthcare
Who is Judo Bio
Judo Bio is a biotechnology company located in Cambridge, Massachusetts. The company employs 19 people. Judo Bio is pioneering the development of oligonucleotide medicines specifically designed for delivery to the kidney. They focus on creating ligand-RNA conjugate drugs using their proprietary STRIKE platform. These drugs are designed to target specific kidney cell types through receptor-mediated uptake, leading to gene silencing and potential therapeutic benefits for systemic and renal diseases. Judo Bio's initial therapeutic pipeline centers around megalin-STRIKERs. These specialized drugs utilize the megalin receptor family to selectively deliver siRNA therapeutics to the proximal tubule of the kidney. This targeted delivery aims to inhibit the uptake of circulating solutes linked to systemic diseases by silencing the mRNA expression of specific solute carrier proteins (SLCs). For more information about Judo Bio and their innovative approach to oligonucleotide medicine, visit their website at judo.bio.
Company Leadership
Companies Similar to Judo Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Judo Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 803 | Deerfield, IL | 2010 | ||
| Buffalo, NY | ||||